West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3047% above fair value
$414.12−3.68 (-0.88%)
Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%
West Pharmaceutical Services total assets
Total assets on the balance sheet at the end of each period.
West Pharmaceutical Services's total assets was $4.06B at Sep 30, 2026. For fiscal 2025 it was $4.27B, up 17.2% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $4.27B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.27B | +17.2% |
| FY2024 | Dec 31, 2024 | $3.64B | -4.9% |
| FY2023 | Dec 31, 2023 | $3.83B | +5.9% |
| FY2022 | Dec 31, 2022 | $3.62B | +9.1% |
| FY2021 | Dec 31, 2021 | $3.31B | +18.6% |
| FY2020 | Dec 31, 2020 | $2.79B | +19.3% |
| FY2019 | Dec 31, 2019 | $2.34B | +18.3% |
| FY2018 | Dec 31, 2018 | $1.98B | +6.2% |
| FY2017 | Dec 31, 2017 | $1.86B | +8.5% |
| FY2016 | Dec 31, 2016 | $1.72B | +1.3% |
| FY2015 | Dec 31, 2015 | $1.70B | +1.5% |
| FY2014 | Dec 31, 2014 | $1.67B | -0.0% |
| FY2013 | Dec 31, 2013 | $1.67B | +6.8% |
| FY2012 | Dec 31, 2012 | $1.56B | +11.8% |
| FY2011 | Dec 31, 2011 | $1.40B | +8.1% |
| FY2010 | Dec 31, 2010 | $1.29B | +1.8% |
| FY2009 | Dec 31, 2009 | $1.27B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.06B | -1.1% |
| Q2 FY2026 | Jun 30, 2026 | $4.08B | +3.1% |
| Q1 FY2026 | Mar 31, 2026 | $4.11B | +13.6% |
| Q4 FY2025 | Dec 31, 2025 | $4.27B | +17.2% |
| Q3 FY2025 | Sep 30, 2025 | $4.11B | +11.7% |
| Q2 FY2025 | Jun 30, 2025 | $3.95B | +13.3% |
| Q1 FY2025 | Mar 31, 2025 | $3.62B | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $3.64B | -4.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.68B | -2.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.49B | -4.9% |
| Q1 FY2024 | Mar 31, 2024 | $3.60B | -3.3% |
| Q4 FY2023 | Dec 31, 2023 | $3.83B | +5.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.75B | +13.2% |
| Q2 FY2023 | Jun 30, 2023 | $3.67B | +9.2% |
| Q1 FY2023 | Mar 31, 2023 | $3.72B | +13.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.62B | +9.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.32B | +5.5% |
| Q2 FY2022 | Jun 30, 2022 | $3.36B | +14.6% |
| Q1 FY2022 | Mar 31, 2022 | $3.29B | +20.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.31B | +18.6% |
| Q3 FY2021 | Sep 30, 2021 | $3.14B | +21.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.93B | +22.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.74B | +22.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.79B | +19.3% |
| Q3 FY2020 | Sep 30, 2020 | $2.58B | +18.8% |
| Q2 FY2020 | Jun 30, 2020 | $2.39B | +12.7% |
| Q1 FY2020 | Mar 31, 2020 | $2.25B | +10.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.34B | +18.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.17B | +11.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.12B | +13.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.04B | +8.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.98B | +6.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.95B | +0.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.87B | +1.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.87B | +7.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.86B | +8.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.93B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.84B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.73B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.72B | – |
See a number that looks wrong?